CD2665

Hormones · In Retinoic acid

Chemical structure of CD2665
Structure: CD2665, PubChem CID 216241

Cells and tissue onlyNot measured in peopleResearch onlySmall molecule

A laboratory chemical that blocks the vitamin A receptor instead of switching it on, which is the reverse of the approved retinoid drugs.

A synthetic retinoid antagonist, described by the authors who tested it as targeting RARγ, the retinoic acid receptor most abundantly expressed in the growth plate. It blocks the receptor rather than activating it, which is the opposite of every approved retinoid. Sold research-use-only.

J Bone Miner Res, 2021

Risks. Never given to a person, so nothing is known. Blocking vitamin A signalling throughout the body would be expected to affect vision, immunity and skin.

On this page

  • At the growth plate, members only
  • Risks and side effects, members only

The rest of this page is for members

What has been measured, in whom, with every source, and what it does to the rest of you. And every article in the library.

Join for $11.99

Lifetime · 3 of 10 founding spots left

Tax is added at checkout (VAT/GST where it applies).

or $9.99 a month

Renews every month at the current price plus tax until you cancel. Cancel from your account before the next monthly charge to stop it.

Card purchases are sold and charged by Link (Stripe) under Link's terms and refund policy.

Educational content, not medical advice. Nothing here is a recommendation to take or stop taking anything — talk to a doctor about your own situation.